Zimmer Biomet using the Apple Watch to collect data from 10,000 joint patients

By

Zimmer Biomet launches clinical trial with Apple Watch (MassDevice)
Zimmer Biomet (NYSE:ZBH) said today that it’s launching a clinical trial using the Apple Watch to help hip and knee replacement patients that could enroll as many as 10,000 patients.
Using the orthopedic giant’s MyMobility app and the Apple Watch, the study aims to evaluate the app’s utility in improving outcomes and lowering costs, Warsaw, Ind.-based Zimmer Biomet said. The study will incorporate patient feedback and continuous health and activity data from the Apple (NSDQ:AAPL) device.
“We are incredibly excited to work wi...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.